ICCM Stock Summary and Trading Ideas (Icecure Medical Ltd. - | NASDAQ:ICCM)

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Icecure Medical Ltd. - trades on the NASDAQ stock market under the symbol ICCM.

As of August 26, 2026, ICCM stock price climbed to $2.30 with 6,135 million shares trading.

ICCM has a beta of 1.99, meaning it tends to be more sensitive to market movements. ICCM has a correlation of 0.03 to the broad based SPY ETF.

ICCM has a market cap of $7.88 million. This is considered a Sub-Micro Cap stock.

Last quarter Icecure Medical Ltd. - reported $889,000 in Revenue and -$1.37 earnings per share. This fell short of revenue expectation by $-777,264 and missed earnings estimates by -$.08.

In the last 3 years, ICCM traded as high as $49.80 and as low as $2.12.

ICCM has underperformed the market in the last year with a price return of -92.4% while the SPY ETF gained +20.3%. ICCM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -67.4% and -34.5%, respectively, while the SPY returned +2.9% and -0.7%, respectively.

ICCM support price is $2.12 and resistance is $2.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ICCM shares will trade within this expected range on the day.